Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (2022 - 2025)

Gossamer Bio's Shares Outstanding history spans 4 years, with the latest figure at $233.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 3.12% year-over-year to $233.7 million; the TTM value through Dec 2025 reached $233.7 million, up 3.12%, while the annual FY2025 figure was $233.7 million, 3.12% up from the prior year.
  • Shares Outstanding reached $233.7 million in Q4 2025 per GOSS's latest filing, up from $231.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $233.7 million in Q4 2025 to a low of $76.6 million in Q1 2022.
  • Average Shares Outstanding over 4 years is $175.5 million, with a median of $225.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 140.02% in 2023, then increased 0.44% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $94.4 million in 2022, then skyrocketed by 138.72% to $225.4 million in 2023, then increased by 0.53% to $226.6 million in 2024, then increased by 3.12% to $233.7 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Shares Outstanding are $233.7 million (Q4 2025), $231.3 million (Q3 2025), and $227.3 million (Q2 2025).